Status:
COMPLETED
Left Atrial Function Changes After Left Atrial Appendage Closure in Patients With Persistent Atrial Fibrillation
Lead Sponsor:
Ruiqin xie
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
Up to 80 years
Phase:
NA
Brief Summary
A total of 105 patients with persistent atrial fibrillation(AF), that lasting longer than one year and planned to undergo surgical treatment, will be allocated into three groups. These patients will r...
Eligibility Criteria
Inclusion
- persistent atrial fibrillation episode occurs in the patient that lasting longer than one year,
- atrial fibrillation cannot be prevented in patients who orally take class I and III antiarrhythmic drugs,
- and patient age is \<80 years.
Exclusion
- patients with previous history of atrial fibrillation ablation, atrial thrombosis, or valvular heart disease (moderate and severe valvular stenosis, severe valvular regurgitation),
- patients who underwent prosthetic heart valve replacement,
- pregnant women,
- patients with existing liver and kidney disease, malignant tumors or hematological system diseases.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03276169
Start Date
October 1 2017
End Date
November 1 2020
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China, 050000